These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3893523)

  • 1. Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology.
    Soria J; Soria C; Borg JY; Mirshahi M; Piguet H; Tron P; Fessard C; Caen JP
    Br J Haematol; 1985 Jul; 60(3):503-14. PubMed ID: 3893523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients.
    Cattaneo M; Kinlough-Rathbone RL; Lecchi A; Bevilacqua C; Packham MA; Mustard JF
    Blood; 1987 Jul; 70(1):221-6. PubMed ID: 3109523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cobaltous chloride on aggregation of platelets from normal and afibrinogenaemic human blood.
    Smith AG; Smith AN
    Toxicol Lett; 1984 Dec; 23(3):349-52. PubMed ID: 6523526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of fibrinogen during ADP- or thrombin-induced aggregation of washed rabbit platelets.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Mustard JF; Tanoue K; Yamazaki H
    J Histochem Cytochem; 1990 Jun; 38(6):869-74. PubMed ID: 2335742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1986 Apr; 77(4):1272-7. PubMed ID: 3007578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet adhesiveness and aggregation in congenital afibrinogenemia. An investigation of three patients with post-transfusion, cross-correction studies between two of them.
    Girolami A; De Marco L; Virgolini L; Peruffo R; Fabris F
    Blut; 1975 Feb; 30(2):87-100. PubMed ID: 1111662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical localization of fibrinogen during thrombin-induced aggregation of washed human platelets.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Tanoue K; Yamazaki H; Mustard JF
    Blood; 1988 May; 71(5):1310-20. PubMed ID: 3359044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of fibrinogen concentrations in suspensions of washed rabbit and human platelets by radioimmunoassays.
    Harfenist EJ; Wrana JL; Packham MA; Mustard JF
    Thromb Haemost; 1985 Feb; 53(1):110-5. PubMed ID: 3992511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical localization of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine diphosphate-induced responses and enhanced fibrinogen binding in a medium with low calcium levels.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Tanoue K; Yamazaki H; Mustard JF
    Blood; 1988 Apr; 71(4):850-60. PubMed ID: 2833330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen fragment D is a recognition site for release-related platelet aggregation.
    Agam G; Shohat O; Livne A
    Thromb Res; 1985 Mar; 37(6):629-38. PubMed ID: 3992532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function by afibrinogenemia.
    Awaad S; Helmy O; Fahmy A; Naga MA; Hassanene A; Wahsh E
    Gaz Egypt Paediatr Assoc; 1976; 24(3-4):185-92. PubMed ID: 1032139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-type plasminogen activator inhibits aggregation of platelets in vitro.
    Mizuta T; Imai C
    Life Sci; 1988; 43(12):955-63. PubMed ID: 3139948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of thrombospondin in platelet aggregation.
    Leung LL
    J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation.
    Molica F; Nolli S; Fontana P; Kwak BR
    J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.